A185
Pill imprint A185 has been identified as Trimethobenzamide hydrochloride 300 mg.
Trimethobenzamide is used in the treatment of nausea/vomiting and belongs to the drug class anticholinergic antiemetics. FDA has not classified the drug for risk during pregnancy.
Trimethobenzamide 300 mg is not subject to the Controlled Substances Act.
See also related documents.
Trimethobenzamide hydrochloride Images
- Imprint:
-
A185
- Strength:
- 300 mg
- Color:
- Purple
- Availability:
- Prescription only
- Drug Class:
- Anticholinergic antiemetics
- Pregnancy Category:
- N - Not yet classified
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Amide Pharmaceutical Inc.
- National Drug Code (NDC):
- 52152-0185
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54569-5589 | A S Medication Solutions LLC (repackager) |
| 68258-9100 | Dispensing Solutions Inc. (repackager) |
| 55887-0081 | Diversified Healthcare Services Inc (repackager) |
| 16590-0570 | Stat RX USA LLC (repackager) |
Note: Inactive ingredients may vary.
More Trimethobenzamide Hydrochloride resources
- Trimethobenzamide (Wolters Kluwer)
- Trimethobenzamide Solution (Wolters Kluwer)
- trimethobenzamide (Cerner Multum)
- Arrestin (Micromedex) - Includes Dosage Information
- Stemetic (Micromedex) - Includes Dosage Information
- Tribenzagan (Micromedex) - Includes Dosage Information
- trimethobenzamide (Micromedex) - Includes Dosage Information
- trimethobenzamide Intramuscular (Micromedex) - Includes Dosage Information
- Trimethobenzamide Hydrochloride (AHFS DI)
- Tigan Injection (FDA)
- Trimethobenzamide (FDA)
- Trimethobenzamide Capsules (FDA)
- Trimethobenzamide Hydrochloride (Wolters Kluwer)


